DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,030,422 | -0.9% | 4,153 | -4.2% | 0.18% | -1.6% |
| Q2 2023 | $1,039,934 | +1.1% | 4,333 | +6.2% | 0.18% | -1.1% |
| Q1 2023 | $1,028,582 | -4.2% | 4,081 | +0.9% | 0.18% | -12.3% |
| Q4 2022 | $1,073,403 | +2.9% | 4,045 | +0.2% | 0.21% | -9.4% |
| Q3 2022 | $1,043,000 | +2.0% | 4,035 | +0.0% | 0.23% | -0.4% |
| Q2 2022 | $1,023,000 | -19.1% | 4,034 | -6.3% | 0.23% | +21.2% |
| Q1 2022 | $1,264,000 | +13.5% | 4,307 | +27.2% | 0.19% | +20.6% |
| Q4 2021 | $1,114,000 | +50.9% | 3,386 | +39.7% | 0.16% | +31.1% |
| Q3 2021 | $738,000 | +59.1% | 2,424 | +40.1% | 0.12% | +56.4% |
| Q2 2021 | $464,000 | +19.3% | 1,730 | +0.1% | 0.08% | +5.4% |
| Q1 2021 | $389,000 | +1.3% | 1,729 | 0.0% | 0.07% | -5.1% |
| Q4 2020 | $384,000 | +51.2% | 1,729 | +46.8% | 0.08% | +32.2% |
| Q3 2020 | $254,000 | +19.2% | 1,178 | -2.0% | 0.06% | +5.4% |
| Q2 2020 | $213,000 | – | 1,202 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |